Podcast: Silicon Valley's FDA

Perspectives on two individuals – James O’Neill and Balaji Srinivasan – under review for potential high-level posts at the US agency, plus lessons learned from how FDA topsiders have been selected in the past.

More from US FDA

More from Agency Leadership